Ajit Dash

机构：UNSW Sydney · ORCID：0000-0003-4033-4614

发表论文 54 篇 · 总被引 2307 次 · h-index 22

代表论文

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial (2021 · Journal of Allergy and Clinical Immunology · 被引 319)
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis (2016 · JCI Insight · 被引 151)
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery (2017 · Expert Opinion on Drug Discovery · 被引 78)
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis (2022 · Journal of Allergy and Clinical Immunology · 被引 68)
Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development (2019 · Clinical Pharmacology & Therapeutics · 被引 44)
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis (2020 · Drug Safety · 被引 41)